World Journal of
Pharmaceutical and Life Sciences

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Indian Science Publications, SOCOLAR, China, Cosmos Impact Factor, Research Bible, Fuchu, Tokyo. JAPAN, Scientific Indexing Services (SIS), Jour Informatics (Under Process), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, International Scientific Indexing, UAE, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Science Library Index, Dubai, United Arab Emirates, International Innovative Journal Impact Factor (IIJIF), Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), Indian citation Index (ICI), IFSIJ Measure of Journal Quality, International Scientific Indexing, UAE (ISI), Web of Science Group (Under Process), Directory of Research Journals Indexing, Scholar Article Journal Index (SAJI), International Scientific Indexing ( ISI ), 



*Dr. Kimmi Seth, Dr. Om Prakash Singh and Dr. Nitesh Anand


Tamaka Shwasa is a well known disease which has been affecting man kind since vedic times. On the basis of its etiopathogenesis and symptoms, disease Tamaka Shwasa can be considered analogous to Bronchial Asthma. Asthma remains one of the commonest breathing problem across the world, and is spreading at a fast rate in developing countries like India. In India prevalence of Asthma has been found to be around 15 % in the majority of surveys. This might be due to the westernization which has brought a drastic change in the lifestyle of human beings. Increasing population, industrialization and deforestation are the contributing factors towards this chronic obstructive pulmonary disease. Asthma has become a challenging problem for the medical world now. In Modern medicine current management of asthma is by providing short term relief to the patient and not the long term relief. Also prolonged used of these drugs is not safe, as it has many adverse effects on human body. As the chronicity of the disease increases, drug dose dependency also increases which ultimately puts the patient into the vicious circle of ‘dependency on drugs’ that ultimately leads to the respiratory failure and loss of precious life. It is the need of the hour to have some safe & effective regime for the management of this troublesome disease Tamaka Shwasa. In Ayurveda detoxification of the body is done effectively and safely, without inducing any drug dependency by making use of various shodhan procedures and shamana medications. Lots of research work has been done at very institutes of ayurveda by making use of various ayurvedic principles. Various Shodhana procedures, classical and self formulations has definitely been proven the efficacy of ayurvedic procedures and medications in the management of disease Tamaka Shwasa. Here also, classical formulation named Shringyadi Churna and Guduchyadi Kwatha mentioned in has successfully been used for the management of the disease Tamaka Shwasa, which not only has provided the decrease in episodic recurrence but also gave the long term relief to the patient without inducing any drug dependency. Aims and Objectives: To evaluate the efficacy of Shringyadi Churna and Guduchyadi Kwatha in the management of Tamaka Shwasa. Materials and Methods: 60 Patients suffering from Tamaka Shwasa and attending the O.P.D. and I.P.D. of P.G. department of Kayachikitsa, Rishikul Campus Haridwar were selected randomly. Patients were investigated as per proforma prepared for the study. In group I Shringyadi Churna was given with ushnodaka as anupana dravya, In group II only Guduchyadi Kwatha was given and in group III Shringyadi Churna was given with Guduchyadi Kwatha as anupana dravya for total duration of 4 weeks, with assessment follow ups of 15 days interval. and follow up was done after 2 months of the completion of the trial. All the patients were kept under strict dietary control during the treatment. Results and Discussion: The observation of the effect of therapy was encouraging and reduced recurrence significantly. Out of 60 patients 55 patients completed the trial, In group I 94.44% patients attained marked improvement whereas 5.55 % patients attained moderate improvement in the symptoms of Tamaka Shwasa. In group II, 64.70% patients attained marked improvement whereas 35.29% patients attained moderate improvement in the symptoms of Tamaka Shwasa. In group III 65% patients attained marked improvement in the symptoms whereas 35% patients attained complete remission of the symptoms of Tamaka Shwasa.

[Full Text Article]


World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .

Best Article of current issue

Download Article : Click here